LurbinectedinSmall cell lung cancer (SCLC)SCLCchemotherapyneuroendocrine carcinoma
…e responses, underscoring the urgent need for novel strategies. Lurbinectedin, an approved second-line therapy for SCLC, is being evaluated i…
1articles mentioning drugs
7drug mentions
1distinct drugs extracted
0%of mentions human-reviewed
Active filtersEntity: Lurbinectedin ×
Lurbinectedin
This drug is selected. Its supporting articles are shown below.